GPM Growth Investors’s GSK GSK Stock Holding History

GPM Growth Investors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,153	Closed	-$212K	–	38
2020 Q2	$212K	Buy	+4,153	New	+$213K	0.16%	35

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

GPM Growth Investors's GSK Position: Q3 2020 in Review

GPM Growth Investors sold out of GSK (GSK) in Q3 2020, closing a stake of 4,153 shares — an estimated $212K sold.

GPM Growth Investors first reported a position in GSK in Q2 2020 and held it in 1 quarter. The position peaked at $212K in Q2 2020. 826 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

GPM Growth Investors reported no remaining GSK position as of Q3 2020 after selling out during the quarter.
GPM Growth Investors sold 4,153 GSK shares in Q3 2020, an estimated $212K.
GPM Growth Investors first reported a position in GSK in Q2 2020 and held it in 1 quarter.
GPM Growth Investors's GSK position peaked at $212K in Q2 2020.
826 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on GPM Growth Investors's 13F filing for Q3 2020, filed 15 Oct 2020.